European Journal of Vascular & Endovascular Surgery
Volume 40, Issue 5 , Pages 599-607 , November 2010

Use of B-Type Natriuretic Peptide to Predict Blood Pressure Improvement after Percutaneous Revascularisation for Renal Artery Stenosis

  • D. Staub

      Affiliations

    • Department of Angiology, University Hospital Basel, Basel, Switzerland
    • First two authors contributed equally to this work.
    • ,
  • T. Zeller

      Affiliations

    • Herz-Zentrum Bad Krozingen, Bad Krozingen, Germany
    • First two authors contributed equally to this work.
    • ,
  • D. Trenk

      Affiliations

    • Herz-Zentrum Bad Krozingen, Bad Krozingen, Germany
    • ,
  • C. Maushart

      Affiliations

    • Department of Internal Medicine, University Hospital Basel, Basel, Switzerland
    • ,
  • H. Uthoff

      Affiliations

    • Department of Angiology, University Hospital Basel, Basel, Switzerland
    • ,
  • T. Breidthardt

      Affiliations

    • Department of Internal Medicine, University Hospital Basel, Basel, Switzerland
    • ,
  • T. Klima

      Affiliations

    • Department of Internal Medicine, University Hospital Basel, Basel, Switzerland
    • ,
  • M. Aschwanden

      Affiliations

    • Department of Angiology, University Hospital Basel, Basel, Switzerland
    • ,
  • T. Socrates

      Affiliations

    • Department of Internal Medicine, University Hospital Basel, Basel, Switzerland
    • ,
  • N. Arenja

      Affiliations

    • Department of Internal Medicine, University Hospital Basel, Basel, Switzerland
    • ,
  • R. Twerenbold

      Affiliations

    • Department of Internal Medicine, University Hospital Basel, Basel, Switzerland
    • ,
  • A. Rastan

      Affiliations

    • Herz-Zentrum Bad Krozingen, Bad Krozingen, Germany
    • ,
  • S. Sixt

      Affiliations

    • Herz-Zentrum Bad Krozingen, Bad Krozingen, Germany
    • ,
  • A.L. Jacob

      Affiliations

    • Division of Interventional Radiology, University Hospital Basel, Petersgraben 4, CH-4031 Basel, Switzerland
    • ,
  • K.A. Jaeger

      Affiliations

    • Department of Angiology, University Hospital Basel, Basel, Switzerland
    • ,
  • C. Mueller

      Affiliations

    • Department of Internal Medicine, University Hospital Basel, Basel, Switzerland
    • Corresponding Author InformationCorresponding author. Tel.: +41 61 265 58 26; fax: +41 61 265 5353.

Received 7 May 2010 ,Accepted 19 July 2010.

References 

  1. Garovic VD, Textor SC. Renovascular hypertension and ischemic nephropathy. Circulation. 2005;112:1362–1374
  2. White CJ. Catheter-based therapy for atherosclerotic renal artery stenosis. Circulation. 2006;113:1464–1473
  3. The ASTRAL Investigators . Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361:1953–1962
  4. Dubel GJ, Murphy TP. The role of percutaneous revascularization for renal artery stenosis. Vasc Med. 2008;13:141–156
  5. Abela R, Ivanova S, Lidder S, Morris R, Hamilton G. An analysis comparing open surgical and endovascular treatment of atherosclerotic renal artery stenosis. Eur J Vasc Endovasc Surg. 2009;38:666–675
  6. Maisel A, Mueller C, Adams K, Anker SD, Aspromonte N, Cleland JG, et al. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail. 2008;10:824–839
  7. Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med. 2004;350:647–654
  8. Wolf K, Kurtz A, Pfeifer M, Höcherl K, Riegger G, Krämer B. Different regulation of left ventricular ANP, BNP and adrenomedullin mRNA in the two-kidney, one-clip model of renovascular hypertension. Pflugers Arch. 2001;442:212–217
  9. Mussalo H, Vanninen E, Ikäheimo R, Hartikainen J. NT-proANP and BNP in renovascular and in severe and mild essential hypertension. Kidney Blood Press Res. 2003;26:34–41
  10. Wiese S, Breyer T, Dragu A, Wakili R, Burkard T, Schmidt-Schweda S, et al. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: influence of angiotensin II and diastolic fiber length. Circulation. 2000;102:3074–3079
  11. Silva JA, Chan AW, White CJ, Collins TJ, Jenkins JS, Reilly JP, et al. Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis. Circulation. 2005;111:328–333
  12. Staub D, Canevascini R, Huegli RW, Aschwanden M, Thalhammer C, Imfeld S, et al. Best duplex-sonographic criteria for the assessment of renal artery stenosis–correlation with intra-arterial pressure gradient. Ultraschall Med. 2007;28:45–51
  13. Bonelli FS, McKusick MA, Textor SC, Kos PB, Stanson AW, Johnson CM, et al. Renal artery angioplasty: technical results and clinical outcome in 320 patients. Mayo Clin Proc. 1995;70:1041–1052
  14. Cheng V, Kazanagra R, Garcia A, Lenert L, Krishnaswamy P, Gardetto N, et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol. 2001;37:386–391
  15. Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC. Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol. 2002;40:976–982
  16. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–S266
  17. Dworkin LD, Cooper CJ. Clinical practice. Renal-artery stenosis. N Engl J Med. 2009;361:1972–1978
  18. Zeller T, Frank U, Müller C, Bürgelin K, Sinn L, Bestehorn H, et al. Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation. 2003;108:2244–2249
  19. Radermacher J, Chavan A, Bleck J, Vitzthum A, Stoess B, Gebel MJ, et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med. 2001;344:410–417
  20. Lai KN, Leung JC, Yandle TG, Fisher S, Nicholls MG. Gene expression and synthesis of natriuretic peptides by cultured human glomerular cells. J Hypertens. 1999;17:575–583
  21. Brunner-La Rocca HP, Kaye DM, Woods RL, Hastings J, Esler MD. Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects. J Am Coll Cardiol. 2001;37:1221–1227
  22. Johansson M, Elam M, Rundqvist B, Eisenhofer G, Herlitz H, Lambert G, et al. Increased sympathetic nerve activity in renovascular hypertension. Circulation. 1999;99:2537–2542
  23. Mueller T, Gegenhuber A, Dieplinger B, Poelz W, Haltmayer M. Capability of B-type natriuretic peptide (BNP) and amino-terminal proBNP as indicators of cardiac structural disease in asymptomatic patients with systemic arterial hypertension. Clin Chem. 2005;51:2245–2251
  24. Staub D, Nusbaumer C, Zellweger MJ, Jonas N, Wild D, Pfisterer M, et al. Use of B-type natriuretic peptide in the detection of myocardial ischemia. Am Heart J. 2006;151:1223–1230

PII: S1078-5884(10)00440-5

doi: 10.1016/j.ejvs.2010.07.013

European Journal of Vascular & Endovascular Surgery
Volume 40, Issue 5 , Pages 599-607 , November 2010

Article Tools

* Image Usage & Resolution